Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomerica

3.68
-0.1608-4.19%
Post-market: 3.790.1100+2.99%17:10 EDT
Volume:69.82K
Turnover:252.19K
Market Cap:9.37M
PE:-1.72
High:4.07
Open:3.79
Low:3.28
Close:3.84
Loading ...

US Stocks Edge Lower; Retail Sales Increase Less Than Expected

Benzinga
·
16 Jan

Biomerica Says UAE Health Ministry Approved Prostrate Cancer Detection Test

MT Newswires Live
·
16 Jan

Biomerica: United Arab Emirates Ministry of Health and Prevention Approves Fortel Psa Screening Test to Detect Early Sign of Prostate Cancer

THOMSON REUTERS
·
16 Jan

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

GlobeNewswire
·
16 Jan

Biomerica Second Quarter 2025 Earnings: US$0.055 loss per share (vs US$0.09 loss in 2Q 2024)

Simply Wall St.
·
16 Jan

Biomerica reports Q2 EPS (6c) vs. (9c) last year

TIPRANKS
·
15 Jan

Biomerica Q2 2025 Revenue $1.64M Vs $1.57M YoY; EPS $(0.06) Vs $(0.09) YoY

Benzinga
·
15 Jan

BRIEF-Biomerica Q2 Net Income USD -950 Thousand

Reuters
·
15 Jan

Biomerica Q2 Operating Expenses USD 1.43 Million

THOMSON REUTERS
·
15 Jan

Biomerica Q2 Net Income USD -950 Thousand

THOMSON REUTERS
·
15 Jan

Biomerica Q2 Gross Margin 27%

THOMSON REUTERS
·
15 Jan

Press Release: Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Dow Jones
·
15 Jan

Sector Update: Health Care Stocks Climb Thursday Afternoon

MT Newswires Live
·
22 Nov 2024

Biomerica inFoods Technology Gets Three International Patents

MT Newswires Live
·
21 Nov 2024

BRIEF-Biomerica Secures Three Key International Patents For inFoods Technology To Address GERD, Crohn’s Disease, And Ulcerative Colitis

Reuters
·
21 Nov 2024

Biomerica Inc: Patents Secured Apply to Countries Under European Patent Organization

THOMSON REUTERS
·
21 Nov 2024

Biomerica Secures Three Key International Patents for Infoods® Technology to Address Gerd, Crohn’s Disease, and Ulcerative Colitis

THOMSON REUTERS
·
21 Nov 2024

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis

GlobeNewswire
·
21 Nov 2024

BRIEF-Nasdaq Grants Biomerica An Additional 180 Days To Meet Listing Compliance Requirements

Reuters
·
07 Nov 2024

Biomerica granted additional 180-day period to meet listing compliance

TIPRANKS
·
07 Nov 2024